ARSENAL MEDICAL, INC.

Profile

Company Names

ARSENAL MEDICAL, INC.

Addresses

480 ARSENAL STREET, WATERTOWN, MA 02472

Phone Numbers

617-393-4600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$16,017,968.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2019-05-24 
$6,017,967.00 
$6,017,967.00 
$0.00 
Equity 
4
2013-08-21 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
3
2012-09-19 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
2
2011-09-09 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
1
2011-08-25 
$1.00 
$1.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JIM 
 
BARRY 
EXECUTIVE OFFICER
ARSENAL MEDICAL, INC.   |  BLACKROCK NTR RENEWABLE POWER FUND (FEEDER B), L.P.   |  BLACKROCK NTR RENEWABLE POWER FUND (A),L.P.   |  BOARDWALK I, L.P.   |  PROJECT GLOW CO-INVESTMENT FUND, L.P.   |  FAIR LANE INVESTMENT PARTNERS, L.P.   |  BLUE PENINSULA FUND, L.P.   |  COASTLINE FUND, L.P.   |  PROJECT FINALE CO-INVESTMENT FUND HOLDINGS, LLC   |  PROJECT FINALE CO-INVESTMENT FUND, L.P.   |  OAK MARSH GLOBAL OPPORTUNITIES FUND, L.P.   |  GLOBAL RENEWABLE POWER FUND II (A), L.P.   |  GLOBAL RENEWABLE POWER FUND II (B), L.P.   |  BOPA1, L.P.   |  NC GARNET FUND, L.P.   |  MULTI-ALTERNATIVE OPPORTUNITIES FUND (A), L.P.   |  MULTI-ALTERNATIVE OPPORTUNITIES FUND (B), L.P.   |  GLOBAL RENEWABLE POWER FUND II (D), L.P.   |  HR US INFRA EQUITY LP   |  EMPIREPM B 2017-10, L.P.   |  GLOBAL ENERGY + POWER INFRASTRUCTURE FUND III A, L.P.   |  GLOBAL ENERGY + POWER INFRASTRUCTURE FUND III D, L.P.   |  GLOBAL ENERGY + POWER INFRASTRUCTURE FUND III F, L.P.   |  GLOBAL ENERGY + POWER INFRASTRUCTURE FUND III B, L.P.   |  GEPIF GLASS MOUNTAIN PIPELINE HOLDINGS LLC   |  TOTAL ALTERNATIVES FUND (B) LP   |  TOTAL ALTERNATIVES FUND (A) LP   |  GEPIF III EMPLOYEE FUND A, L.P.   |  GEPIF III EMPLOYEE FUND D, L.P.   |  MOUNTAIN RESEARCH FUND, L.P.   |  CAPITOL HILL CO-INVESTMENT FUND, L.P.   |  MWA FUND OF ONE, L.P.   |  GLOBAL RENEWABLE POWER INFRASTRUCTURE FUND III (D), L.P.   |  GLOBAL RENEWABLE POWER INFRASTRUCTURE FUND III (B), L.P.   |  GLOBAL RENEWABLE POWER INFRASTRUCTURE FUND III (A), L.P.   |  BIS NYC INFRASTRUCTURE EMERGING MANAGER OPPORTUNITIES FUND, L.P.   |  BIS BRAZOS INFRASTRUCTURE FUND, L.P.   |  GLOBAL INFRASTRUCTURE DEBT ISSUER LP   |  GEPIF III COYOTE INVESTCO L.P.
EARL 
M. 
COLLIER 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
FITZGERALD 
EXECUTIVE OFFICER
JAMIE 
 
GOLDSTEIN 
DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
RICHARD 
MOTT 
DIRECTOR
UPMA 
 
SHARMA 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-08-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-09-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#